Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Apotex Announces $184 Million Investment to Grow U.S. Manufacturing Presence; Expansion Plan Comprises Company’s Largest Investment in the United States

Advanced R&D, Manufacturing, and Packaging Facility to Serve as U.S. Headquarters; Initially Expected to Create Minimum of 150 Full-Time Jobs BROWARD COUNTY, Fla., March 8, 2017 /PRNewswire/ — Today Apotex Inc., the largest Canadian owned pharmaceutical company, announced the details of a $184 million U.S. expansion plan, including the development of a new R&D center […]

Read More »

FDA Grants Orphan Drug Designation to CSRA’s DynPort Vaccine Company for Plague Vaccine

DynPort’s clinical stage recombinant Yersinia pestis rF1V plague vaccine to benefit from FDA Orphan Drug Designation FALLS CHURCH, Va., March 8, 2017 /PRNewswire/ — CSRA Inc. (NYSE: CSRA) today announced that a plague vaccine being developed by its subsidiary, DynPort Vaccine Company LLC (DVC), was granted Orphan Drug Designation from the U.S. Food and Drug Administration […]

Read More »

AstraZeneca PLC Had ‘Fake Doctor’ Under Payroll in Australia

Global pharma giant AstraZeneca (AZN) employed a man in Australia who allegedly falsified his credentials to pose as a doctor, according to reports from the Australian Broadcast Company. Shyam Acharya allegedly stole the identity of Sarang Chitale, a doctor based in India, and gained registration with the Medical Board of New South Wales in 2003, […]

Read More »

Former Millennium and FORUM Pharma CEO Resurfaces to Helm Massachusetts Biotech XTuit

March 8, 2017 By Mark Terry, BioSpace.com Breaking News Staff Waltham, Mass.-based XTuit Pharmaceuticals announced today that Deborah Dunsire was stepping in as president, chief executive officer, and board member. She is replacing replacing interim chief executive officer Alan Crane, a partner with Polaris Partners. Dunsire is well known within the biotech industry. She spent […]

Read More »

Pfizer Eyes $100 Million Expansion, New Jobs in North Carolina

Pfizer has its eyes set on a possible $100 million investment to expand a plant in Sanford, N.C. with a focus on gene therapy, according to the Triangle Business Journal. The investment would include the addition of 50 new jobs.

Read More »

South Korea culls 50,000 farm birds as 2 new bird flu cases confirmed

South Korea has culled some 50,000 farm birds as two cases of bird flu were confirmed on Wednesday, bringing the country’s cull this winter to nearly 35 million – more than a fifth of all South Korean poultry – since a first bird flu case was found late last year. The Ministry of Agriculture, Food […]

Read More »

House panels to launch fight in Congress over Obamacare replacement

A potentially lengthy U.S. legislative fight over replacement of the Obamacare health law got underway as two House of Representatives committees begin negotiating over changes to a Republican plan backed by President Donald Trump.

Read More »

Oscar Winner Turned Pharma CEO: We’ll Prevent Genital Herpes

Oscar winning producer Agustin Fernandez III wanted to make a difference in healthcare. But, he did not want to be someone who disrupts the industry, he wants to be a transformative force in the lives of people suffering from genital herpes.

Read More »

Trump backs House Republican healthcare plan

President Donald Trump backed a draft U.S. House of Reps’ Republican bill to repeal and replace the Obamacare healthcare law that is open to negotiation.

Read More »

U.S. reports low pathogenic bird flu outbreak in Wisconsin: OIE

The United States reported an outbreak of avian flu on a farm in Wisconsin, the second in the country in less than a week although the virus found this time is considered less virulent, the World Organisation for Animal Health (OIE) said.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom